statistiche ricercatore

VISCA, DINA

Distribuzione geografica

Continente	#
NA - Nord America	5.737
EU - Europa	2.674
AS - Asia	1.852
SA - Sud America	334
AF - Africa	36
OC - Oceania	13
Continente sconosciuto - Info sul continente non disponibili	6
Totale	10.652

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	5.664
IT - Italia	1.457
SG - Singapore	740
HK - Hong Kong	349
CN - Cina	305
UA - Ucraina	286
BR - Brasile	278
VN - Vietnam	253
IE - Irlanda	195
SE - Svezia	154
DE - Germania	153
GB - Regno Unito	133
RU - Federazione Russa	103
TR - Turchia	75
AT - Austria	48
FI - Finlandia	48
CA - Canada	39
MX - Messico	29
AR - Argentina	27
JP - Giappone	26
BD - Bangladesh	20
IN - India	17
ES - Italia	15
PL - Polonia	14
ZA - Sudafrica	14
CL - Cile	13
AU - Australia	12
CZ - Repubblica Ceca	12
FR - Francia	12
NL - Olanda	11
ID - Indonesia	9
PK - Pakistan	9
IQ - Iraq	7
IR - Iran	7
RO - Romania	7
LT - Lituania	6
EC - Ecuador	5
EU - Europa	5
MY - Malesia	5
SA - Arabia Saudita	5
AE - Emirati Arabi Uniti	4
KZ - Kazakistan	4
AL - Albania	3
BE - Belgio	3
EG - Egitto	3
MD - Moldavia	3
SN - Senegal	3
BH - Bahrain	2
CH - Svizzera	2
CO - Colombia	2
DK - Danimarca	2
DZ - Algeria	2
GN - Guinea	2
JO - Giordania	2
KE - Kenya	2
LK - Sri Lanka	2
MA - Marocco	2
OM - Oman	2
PE - Perù	2
PY - Paraguay	2
UY - Uruguay	2
UZ - Uzbekistan	2
VE - Venezuela	2
A2 - ???statistics.table.value.countryCode.A2???	1
AM - Armenia	1
AZ - Azerbaigian	1
BO - Bolivia	1
CI - Costa d'Avorio	1
CR - Costa Rica	1
CY - Cipro	1
ET - Etiopia	1
GD - Grenada	1
GE - Georgia	1
GR - Grecia	1
HN - Honduras	1
HU - Ungheria	1
JM - Giamaica	1
KG - Kirghizistan	1
KH - Cambogia	1
LY - Libia	1
MU - Mauritius	1
MZ - Mozambico	1
NO - Norvegia	1
NZ - Nuova Zelanda	1
PA - Panama	1
PT - Portogallo	1
QA - Qatar	1
RS - Serbia	1
SI - Slovenia	1
SK - Slovacchia (Repubblica Slovacca)	1
TN - Tunisia	1
UG - Uganda	1
ZM - Zambia	1
Totale	10.652

Salva come PNG Salva come JPEG

Città	#
Milan	1.009
Fairfield	746
Ashburn	557
Singapore	376
Woodbridge	351
Hong Kong	348
Chandler	337
Houston	307
Seattle	286
Wilmington	286
Cambridge	279
Jacksonville	270
Dallas	197
Dublin	189
Princeton	182
Beijing	148
Ann Arbor	134
Boardman	122
Nyköping	99
Chicago	97
New York	97
Dearborn	93
Rome	91
Dong Ket	89
The Dalles	85
San Diego	76
Los Angeles	75
London	63
Izmir	62
Ogden	45
Munich	44
São Paulo	39
Helsinki	34
Vienna	29
Santa Clara	28
Ho Chi Minh City	27
Nuremberg	27
Salt Lake City	25
San Francisco	22
Mexico City	21
Redmond	21
Tokyo	20
Hanoi	19
San Genesio Ed Uniti	19
Washington	18
Como	17
Norwalk	14
Tampa	14
Atlanta	13
Montreal	13
Toronto	12
Warsaw	12
Belo Horizonte	11
Brno	11
Buffalo	11
Hefei	11
Kunming	11
Varese	11
Brooklyn	10
Phoenix	10
Orem	9
Pavia	9
Cedar Knolls	8
Elk Grove Village	8
Johannesburg	8
Kilburn	8
Magnago	8
Rio de Janeiro	8
Stockholm	8
Chennai	7
Denver	7
Dhaka	7
Falkenstein	7
Biên Hòa	6
Boston	6
Lancaster	6
Lappeenranta	6
Redwood City	6
Cavaria con Premezzo	5
Chiswick	5
Guangzhou	5
Jakarta	5
Kansas City	5
Manchester	5
Miami	5
Nanjing	5
Shanghai	5
Venice	5
Amsterdam	4
Beauharnois	4
Changsha	4
Charlotte	4
Espoo	4
Frankfurt am Main	4
Gujranwala	4
Hải Dương	4
Manassas	4
Melbourne	4
Nanchang	4
North Bergen	4
Totale	7.900

Salva come PNG Salva come JPEG

Nome	#
Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases	304
Adverse Reactions to Food: Allergies and Intolerances	229
Classifying new anti-tuberculosis drugs: rationale and future perspectives	225
Adherence to Continuous Positive Airway Pressure in patients with Obstructive Sleep Apnoea. A ten year real life study	208
Airway inflammatory phenotypes: Making sputum cell evaluation more accessible for clinical use	196
Pulmonary rehabilitation is effective in patients with tuberculosis pulmonary sequelae	181
When kidneys and lungs suffer together	181
Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial	162
Intestine: Organ or Apparatus?	162
Cardiovascular function in pulmonary emphysema	158
Do blood eosinophils strictly reflect airway inflammation in COPD? Comparison with asthmatic patients	158
Ambulatory oxygen in fibrotic lung disease (AmbOx): study protocol for a randomised controlled trial	155
Managing severe tuberculosis and its sequelae: from intensive care to surgery and rehabilitation.	154
Is bronchodilator the correct treatment for COPD subjects before EBUS?	152
Ambulatory oxygen in interstitial lung disease	152
Tuberculosis elimination: Where are we now?	149
Inhalation therapy in the next decade: Determinants of adherence to treatment in asthma and COPD	148
Classification of Malabsorption Syndromes	148
Effectiveness of pulmonary rehabilitation in severe asthma: a retrospective data analysis	147
Non-invasive mechanical ventilation in patients with diffuse interstitial lung diseases	146
Outcomes of patients with drug-resistant-tuberculosis treated with bedaquiline-containing regimens and undergoing adjunctive surgery	142
Ventilatory response to carbon dioxide output in subjects with congestive heart failure and in patients with COPD with comparable exercise capacity	141
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: a global feasibility study	140
Combined treatment of drug-resistant tuberculosis with bedaquiline and delamanid: A systematic review	139
Serum interleukin 6 is predictive of early functional decline and mortality in interstitial lung disease associated with systemic sclerosis	138
Relationship between diabetes and respiratory diseases—Clinical and therapeutic aspects	131
World TB Day 2017: Strengthening the fight against TB	130
New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis	130
Eligibility for the shorter regimen for multidrug-resistant tuberculosis in Mexico	129
Inhalation therapy devices for the treatment of obstructive lung diseases: the history of inhalers towards the ideal inhaler	129
Oxygen therapy in COPD and interstitial lung disease: navigating the knowns and unknowns	128
Idiopathic pulmonary fibrosis and sleep disorders: no longer strangers in the night	127
Fecal calprotectin concentrations in alcoholic patients	126
Care-Related intervention in Rehabilitative Pneumology: Pulmonary Rehabilitation in Chronic Obstructive Broncopneumopathies (COPD) can benefit from a multidisciplinary approach? [Cure correlate in Pneumologia Riabilitativa: La Riabilitazione Polmonare nelle Broncopneumopatie Croniche Ostruttive (BPCO) può trarre beneficio da un approccio multidisciplinare?]	121
Evolution of programmatic definitions used intuberculosis prevention and care	121
Blood pressure increase after Pfizer/BioNTech SARS-CoV-2 vaccine	116
Electrocardiographic features of patients with COVID-19 pneumonia	115
Minimal clinically important difference of the 6-min walking test in patients with asthma	113
Pulmonary Rehabilitation and Asthma	112
Multi and extensively drug-resistant pulmonary tuberculosis: Advances in diagnosis and management	109
A snapshot of exhaled nitric oxide and asthma characteristics: experience from high to low income countries	108
The 5-repetition sit-to-stand test as an outcome measure for pulmonary rehabilitation in subjects with asthma	107
Is Two Better Than One? The Impact of Doubling Training Volume in Severe COPD: A Randomized Controlled Study	106
The role of blood gas analysis in the post-acute phase of COVID-19 pneumonia	105
Functional impairment during post-acute COVID-19 phase: Preliminary finding in 56 patients	100
Severity of COVID-19: The importance of being hypertensive	96
MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network	94
Pleuroparenchymal fibroelastosis in systemic sclerosis: prevalence and prognostic impact	93
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: First global report	90
Tuberculosis, COVID-19 and migrants: Preliminary analysis of deaths occurring in 69 patients from two cohorts	90
Electrocardiographic features of patients with COVID-19: One year of unexpected manifestations	90
Mepolizumab Improves Outcomes of Chronic Rhinosinusitis with Nasal Polyps in Severe Asthmatic Patients: A Multicentric Real-Life Study	89
Combined use of electrocardiography and ultrasound to detect cardiac and pulmonary involvement after recovery from COVID-19 pneumonia: A case series	87
Chronic cough in adults	85
Time course of exercise capacity in patients recovering from COVID-19-associated pneumonia. Authors' reply	84
Effects of biological therapies on chronic rhinosinusitis in severe asthmatic patients	80
Pulmonary rehabilitation in patients recovering from COVID-19	80
Tuberculosis and COVID-19 co-infection: description of the global cohort	80
Something is changing in adherence to CPAP therapy: Real world data after 1 year of treatment in patients with obstructive sleep apnoea	79
Effectiveness of a Pulmonary Rehabilitation Program on Persistent Asthma Stratified for Severity	79
SARS-CoV-2 vaccines: Lights and shadows	79
Analysis of Patients with Asthma and Mixed Granulocytic Inflammatory Pattern in Sputum	78
Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort	77
Post-TB disease: a new topic for investigation-and why it matters	76
Cost-effectiveness of ambulatory oxygen in improving quality of life in fibrotic lung disease: Preliminary evidence from the AmbOx Trial	75
Serum markers of pulmonary epithelial damage in systemic sclerosis-associated interstitial lung disease and disease progression	72
Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: comment	72
Pulmonary rehabilitation in patients with interstitial lung diseases: Correlates of success	71
Clinical standards for the assessment, management and rehabilitation of post-TB lung disease	68
Defining genetic risk factors for scleroderma-associated interstitial lung disease: IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease	67
Pulmonary rehabilitation: Promising nonpharmacological approach for treating asthma?	66
High-flow oxygen therapy during exercise training in patients with chronic obstructive pulmonary disease and chronic hypoxemia: A multicenter randomized controlled trial	66
Rehabilitation, optimized nutritional care, and boosting host internal milieu to improve long-term treatment outcomes in tuberculosis patients	65
Predictive value of blood eosinophils and exhaled nitric oxide in adults with mild asthma: a prespecified subgroup analysis of an open-label, parallel-group, randomised controlled trial	65
Joint effect of heart failure and coronary artery disease on the risk of death during hospitalization for COVID-19	65
Severe asthma: One disease and multiple definitions	65
Post tuberculosis treatment infectious complications	64
Coronavirus Disease-19: An Interim Evidence Synthesis of the World Association for Infectious Diseases and Immunological Disorders (Waidid)	63
Tuberculosis and COVID-19 interaction: A review of biological, clinical and public health effects	63
Epidemic and pandemic viral infections: Impact on tuberculosis and the lung	61
Correction to: When kidneys and lungs suffer together (Journal of Nephrology, (2019), 32, 5, (699-707), 10.1007/s40620-018-00563-1)	61
Physiological predictors of exertional oxygen desaturation in patients with fibrotic interstitial lung disease	60
Tuberculosis in the time of COVID-19: quality of life and digital innovation	59
Post-tuberculosis lung disease: a comparison of Brazilian, Italian, and Mexican cohorts	59
Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life	58
Renin Angiotensin System Blockers and Risk of Mortality in Hypertensive Patients Hospitalized for COVID-19: An Italian Registry	58
Time course of exercise capacity in patients recovering from covid-19-associated pneumonia	57
History of prevention, diagnosis, treatment and rehabilitation of pulmonary sequelae of tuberculosis	55
The Maugeri daily activity profile: A tool to assess physical activity in patients with chronic obstructive pulmonary disease	54
Post-tuberculosis sequelae: The need to look beyond treatment Outcome	53
Clinical risk scores for the early prediction of severe outocomes in patients hospitalized for COVID-19: comment	53
Management of chronic refractory cough in adults	52
A systematic review of the costs of diagnosis for multidrug-resistant/extensively drug-resistant TB in different settings	51
Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy	51
The need for pulmonary rehabilitation following tuberculosis treatment	49
Post-tuberculosis (TB) treatment: The role of surgery and rehabilitation	49
Current developments and future directions in COPD	48
Tuberculosis, COVID-19 and hospital admission: Consensus on pros and cons based on a review of the evidence	47
Brazilian Thoracic Association recommendations for the management of post-tuberculosis lung disease	44
An overview of Cochrane systematic reviews for pulmonary rehabilitation interventions in people with chronic obstructive pulmonary disease: a mapping synthesis	44
Totale	10.314

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	62.777
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	62.777

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	1.261	0	0	0	0	0	105	78	157	303	132	195	291
2021/2022	970	147	27	64	11	33	63	85	72	58	244	69	97
2022/2023	1.055	102	82	104	132	58	227	6	109	133	49	21	32
2023/2024	1.808	248	259	245	301	374	154	72	18	75	39	6	17
2024/2025	1.880	20	25	281	50	74	140	67	76	237	275	176	459
2025/2026	1.678	314	272	247	485	312	48	0	0	0	0	0	0
Totale													11.006